CLINICAL_TRIALS
withdrawal
· 2016-06-15
Clinical Trial Update: Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME)
Summary
The CT PRIME trial, assessing coronary CT angiography as the primary initial evaluation for subacute chest pain, has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Corewell Health East | Conditions: Coronary Artery Disease | Status: WITHDRAWN